ScreenCell® logo
Quote

Our clinical trials

Our clinical trials aim to demonstrate the clinical utility of circulating tumor cells in the care pathway of cancer patients, using ScreenCell® technology.

Clinical Studies

Filter by

Type of cancer

Clinical studies registry

Ex Vivo Expansion of Circulating Tumor Cells as a Model for Cancer Predictive Pharmacology (EXPEVIVO-CTC)

Type of cancer:

  • Mélanoma

Status of the study:

  • In progress

Promoter:

  • APHP / Hôpital Saint Louis

Investigative center:

  • APHP / Hôpital Saint Louis

Evaluation of Circulating Tumor Cells (CTC) Relevance in Breast Cancer Follow-up Using the ScreenCell Device (PROBE-CTC)

Type of cancer:

  • Breast cancer

Status of the study:

  • In progress

Promoter:

  • ScreenCell®

Investigative center:

  • CMC Ambroise Paré Hartmann

Analysis of circulating tumor cells (CTCs) in patients with metastatic melanoma before and during systemic treatment

Type of cancer:

  • Metastatic melanoma

Status of the study:

  • In progress

Promoter:

  • Institut Gustave Roussy

Investigative center:

  • Institut Gustave Roussy

Evaluation of Circulating Tumor Cells (CTCs) by the ScreenCell® device in breast cancer: validation of biomarkers

Type of cancer:

  • Metastatic breast cancer

Status of the study:

  • Completed

Promoter:

  • ScreenCell®

Investigative center:

  • Laboratoire Dr Kahia Tani

Tell us about your project

Are you interested in establishing a fundamental or clinical research project focused on circulating tumor cells (CTCs) or liquid biopsy ?

Share your project details with us, and we will be delighted to assist you in bringing it to fruition.

Liquid biopsy for
enhancing patient care
through reliable CTC analysis
Request a quote
Request the brochure